Vanguard Global Advisers’s IDEAYA Biosciences IDYA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.58M Buy
41,028
+5,377
+15% +$203K ﹤0.01% 1415
2026
Q2
$1.33M Sell
35,651
-1,009
-3% -$30.9K ﹤0.01% 1562
2026
Q1
$1.22M Buy
+36,660
New +$1.23M ﹤0.01% 1517

Other funds holding IDYA

Vanguard Global Advisers's IDYA Position: Q3 2026 in Review

Vanguard Global Advisers increased its IDEAYA Biosciences (IDYA) stake by 15% in Q3 2026, buying an estimated $203K and bringing the position to 41,028 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1415.

Vanguard Global Advisers first reported a position in IDYA in Q1 2026 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold IDYA as of Q3 2026.

  • Vanguard Global Advisers held 41,028 shares of IDEAYA Biosciences worth $1.58M as of Q3 2026.
  • Vanguard Global Advisers bought 5,377 IDEAYA Biosciences shares in Q3 2026, an estimated $203K.
  • IDEAYA Biosciences made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1415 holding.
  • Vanguard Global Advisers first reported a position in IDEAYA Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.